ransomnote: Spike proteins. Why is it alway spike proteins. We know by now how damaging they are and so they start referring to them as 'protein subunit' vaccines now..... :(
From Wikipedia
"Nanocovax is a Vietnamese COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology JSC.[1][2][3][4] It is a subunit vaccine (SARS‑CoV‑2 recombinant spike protein with aluminum adjuvant).[2]"
ransomnote: Ridiculously short and small participant co-horts. They aren't even trying to pretend to be careful - just shove that stuff in arms.
On 7 December, the National Institute of Hygiene and Epidemiology (Vietnam) announced the Nanocovax test results on hamsters. The hamsters were vaccinated and then exposed to the novel coronavirus for 14 days. They were not infected and results from lung fluid tests also showed they were negative for the virus. Meanwhile, mice that were not vaccinated tested positive for the novel coronavirus and showed signs of fatigue.[5] On 17 December 2020, Nanogen commenced human trials of Nanocovax vaccine.[6][7]
The clinical trial Phase 1 (open-label, dose-escalation) recruited 60 healthy Vietnamese adult volunteers to evaluate the safety, tolerability, and initial assessment of immunogenicity of the vaccine intramuscularly in the participants. The first-stage trials of Nano Covax showed the vaccine was safe and vaccinated volunteers had antibodies against the Alpha variant.[8]
On 26 February 2021, the pharmaceutical company began second phase trials in two places, Hanoi and southern province of Long An.[9] The clinical trial Phase 2 (randomization, double-blind, multicenter, placebo-controlled) enrolled 560 healthy volunteers to evaluate the safety, immunogenicity, and determined the optimal dose of the vaccine intramuscularly in participants. From 25 March to 6 April, volunteers receiving the first jabs in phase II between 26 February and 10 March were given the second shots of the Nanocovax vaccine.[10] Some volunteers experienced side effects around the injection site, yet did not require medical intervention.[11]
Results of the trial issued in April 2021 show the homegrown COVID-19 vaccine is safe.[12] According to the trial results, people injected with 25mcg dose got the highest index with more than 90% at 14 days after the second shot and 42 days since the first doses. The research team is expected to submit a report to the Research Ethics Committee of the Ministry of Health and propose a plan for the third phase of human trials, possibly on 5 May.[13]
In April 2021, the representative of Nanogen JSC said that the third phase of the Nanocovax vaccine trial is expected to start in May and finish at the end of June, 3 months earlier than planned. The third phase of human trials is expected to involve 10,000-15,000 people in both Vietnam and Asian countries with severe outbreaks. Volunteers will be administered with 25mcg – the only dose for this stage. Each person will receive two jabs. They are set to get second shots 28 days after the first one.[14][13]
In June 2021, Nanocovax entered phase III of clinical trials on 13,000 volunteers.[15] The clinical trial Phase 3 (adaptive, multicenter, randomized, double-blind, placebo-controlled) enrolled volunteer subjects 18 years of age and older to evaluate the safety, immunogenicity, and efficacy of Nanocovax vaccine in participants.[16]
Can not be repeated enough.
The evil ones are trying to take advantage of the vulnerable.